Qutenza
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Peripheral Neuropathic Pain
Conditions
Post-operative Peripheral Neuropathic Pain
Trial Timeline
Jan 1, 2014 → Aug 1, 2015
NCT ID
NCT02171182About Qutenza
Qutenza is a pre-clinical stage product being developed by Astellas Pharma for Post-operative Peripheral Neuropathic Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02171182. Target conditions include Post-operative Peripheral Neuropathic Pain.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02171182 | Pre-clinical | Completed |
| NCT01478607 | Phase 3 | Completed |
| NCT01252160 | Approved | Completed |
Competing Products
18 competing products in Post-operative Peripheral Neuropathic Pain